Depression Symptoms Linked to Fundamental Energy Alterations in Brain and Blood Cells

Researchers from the University of Queensland (UQ) and the University of Minnesota have identified distinct patterns in adenosine triphosphate (ATP) levels within the brain and blood cells of young individuals diagnosed with Major Depressive Disorder (MDD). This discovery suggests that symptoms associated with depression may originate from fundamental alterations in how brain and blood cells utilize energy, potentially leading to new avenues for earlier diagnosis and more targeted treatment approaches.

Study Design and Novel Findings

The collaborative study focused on analyzing levels of adenosine triphosphate (ATP), a molecule crucial for cellular energy, in young individuals with MDD. Associate Professor Susannah Tye from UQ’s Queensland Brain Institute (QBI) noted that this research represents the initial instance where these specific fatigue-related molecular patterns have been detected in both the brain and bloodstream of young people with MDD.

For the study, a team at the University of Minnesota collected brain scans and blood samples from 18 participants aged 18 to 25 who had received an MDD diagnosis. These samples were subsequently analyzed by the QBI team and compared against samples from control participants without depression. The study was overseen by Dr. Katie Cullen of the University of Minnesota, and Professors Xiao Hong Zhu and Wei Chen developed the imaging method utilized to quantify ATP production in the brain.

Atypical Cellular Energy Patterns Observed

Dr. Roger Varela, a QBI researcher, reported that cells from individuals with depression exhibited an atypical energy production pattern.

During periods of rest, these cells displayed elevated levels of energy molecule production. However, they demonstrated a diminished capacity to increase energy output when subjected to stress.

This finding was unexpected, as lower energy production might typically be assumed in individuals with depression. Dr. Varela suggested this indicates that cells may be operating at an elevated capacity in the initial phases of the illness, which could potentially contribute to subsequent long-term issues. This reduced ability of mitochondria, the energy-producing organelles, in the brain and body to manage increased energy demands may contribute to common MDD symptoms such as low mood, reduced motivation, and impaired cognitive function.

Implications for Diagnosis, Treatment, and De-Stigmatization

The researchers indicated that these findings could facilitate early intervention and the development of more targeted treatments for MDD. Fatigue is a persistent and challenging symptom of MDD, and progress in developing new treatments has been limited.

Dr. Varela also stated that this research aims to contribute to de-stigmatizing depression by illustrating that the condition involves multiple physiological changes, including those in the brain and blood, and impacts energy at a cellular level. He further emphasized that not all cases of depression are identical, with patient biology and impact varying individually. The researchers aim for this work to lead to the creation of more specific and effective treatment options tailored to these individual differences.

The research findings have been published in the journal Translational Psychiatry.